Pancreatic Cancer Research

ResearcherUniversity Health NetworkNo recent work listed

Oliver A. Kent

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-6494-4383; OpenAlex author ID A5052294382. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: none · 2014: none · 2015: none · 2016: none · 2017: 1 paper · 2018: 1 paper

Papers 3

  1. Increased mutant KRAS gene dosage drives pancreatic cancer progression: evidence for wild-type KRAS as a tumor suppressor? Co-author DOI 10.21037/hbsn.2018.07.03↗
  2. An oncogenic KRAS transcription program activates the RHOGEF ARHGEF2 to mediate transformed phenotypes in pancreatic cancer. Co-author DOI 10.18632/oncotarget.13152↗
  3. Restitution of tumor suppressor microRNAs using a systemic nanovector inhibits pancreatic cancer growth in mice. Co-author DOI 10.1158/1535-7163.mct-11-0152↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. María José Sandí · 1 shared paper, 2017 · strength 0.09
  2. Robert K. Rottapel · 1 shared paper, 2017 · strength 0.09
  3. Joshua T Mendell · 1 shared paper, 2011 · strength 0.03
  4. Dipankar Pramanik · 1 shared paper, 2011 · strength 0.03
  5. Anirban Maitra · 1 shared paper, 2011 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.